In January 2013, Russia implemented its current device law, Resolution 1416. The Russian market offers substantial opportunity for medical device and IVD manufacturers. However, the regulatory system continues to challenge companies with its lack of transparency and complex regulatory structure. In this white paper we discuss the changing regulatory landscape, the challenges facing manufacturers who wish to enter Russia, and changes expected to be introduced.
In this white paper:
About the Author:
Christine Hall is the Manager, International Operations at Emergo.
我们的专家将详细解读2023年韩国食品药品安全部(MFDS)指导文件草案更新下韩国医疗器械注册监管要求、分类标准、韩国良好生产规范(KGMP)等相关要求,并将依据多年韩国本地注册经验提供注册案例分享。此外,您还将了解到制造商在面对MFDS监管时需要关注的核心要点,相关研讨会内容包括:
阅读更多